Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Julphar
Novartis
Federal Trade Commission
Harvard Business School
Accenture
Teva
US Department of Justice
Boehringer Ingelheim
Fuji

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,858,576

« Back to Dashboard

Summary for Patent: 6,858,576
Title: Methods for regulating gastrointestinal motility
Abstract:Methods for reducing gastric motility and delaying gastric emptying for therapeutic and diagnostic purposes are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist. Methods for treating conditions associated with elevated, inappropriate, or undesired post-prandial blood glucose levels are disclosed which comprise administration of an effective amount of an exendin or an exendin agonist alone or in conjunction with other anti-gastric emptying agents.
Inventor(s): Young; Andrew A. (San Diego, CA), Gedulin; Bronislava (San Diego, CA), Beeley; Nigel Robert Arnold (Solana Beach, CA), Prickett; Kathryn S. (San Diego, CA)
Assignee: Amylin Pharmaceuticals, Inc. (San Diego, CA)
Application Number:08/908,867
Patent Claim Types:
see list of patent claims
Use; Compound;

Drugs Protected by US Patent 6,858,576

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,858,576

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 304864 ➤ Sign Up
Austria 381939 ➤ Sign Up
Austria 383867 ➤ Sign Up
Austria 417622 ➤ Sign Up
Austria 493998 ➤ Sign Up
Australia 1404699 ➤ Sign Up
Australia 1458899 ➤ Sign Up
Australia 2003200129 ➤ Sign Up
Australia 2003203955 ➤ Sign Up
Australia 2006225176 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Dow
Citi
Julphar
Accenture
McKinsey
Baxter
Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot